MORIZZO, ERIKA
 Distribuzione geografica
Continente #
NA - Nord America 458
EU - Europa 80
AS - Asia 46
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 586
Nazione #
US - Stati Uniti d'America 458
CN - Cina 26
IT - Italia 20
UA - Ucraina 16
FI - Finlandia 15
DE - Germania 12
VN - Vietnam 11
SE - Svezia 9
SG - Singapore 9
GB - Regno Unito 6
IE - Irlanda 2
AR - Argentina 1
EU - Europa 1
Totale 586
Città #
Jacksonville 85
Fairfield 68
Chandler 37
Wilmington 31
Woodbridge 29
Ashburn 23
Cambridge 20
Houston 20
Seattle 19
Princeton 18
Ann Arbor 10
Dong Ket 10
Boardman 8
San Diego 8
Beijing 7
Des Moines 7
Cagliari 6
Helsinki 6
Nanjing 5
Columbus 4
Nanchang 4
London 3
Munich 3
Singapore 3
Changsha 2
Dublin 2
Hebei 2
Indiana 2
Medford 2
Norwalk 2
Rome 2
Vicenza 2
Borås 1
Buenos Aires 1
Ho Chi Minh City 1
Hounslow 1
Jiaxing 1
Kharkiv 1
Mountain View 1
Ogden 1
Redwood City 1
Roxbury 1
Shenyang 1
Tappahannock 1
Tianjin 1
Totale 463
Nome #
Pyrazolo-triazolo-pyrimidines as adenosine receptor antagonists: Effect of the N-5 bond type on the affinity and selectivity at the four adenosine receptor subtypes 101
2-Phenylpyrazolo[4,3-d]pyrimidin-7-one as a New Scaffold To Obtain Potent and Selective Human A(3) Adenosine Receptor Antagonists: New Insights into the Receptor-Antagonist Recognition 82
A novel class of pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidines as A(3) adenosine receptor antagonists 68
4-amido-2-aryl-1,2,4-triazolo[4,3-a]quinoxalin-1-ones as new potent and selective human A(3) adenosine receptor antagonists. synthesis, pharmacological evaluation, and ligand-receptor modeling studies 63
Scouting human A(3) adenosine receptor antagonist binding mode using a molecular simplification approach: From triazoloquinoxaline to a pyrimidine skeleton as a key study 56
Pyrido[2,3-e]-1,2,4-triazolo[4,3-a]pyrazin-1-one as a New Scaffold To Develop Potent and Selective Human A(3) Adenosine Receptor Antagonists. Synthesis, Pharmacological Evaluation, and Ligand-Receptor Modeling Studies 51
G Protein-Coupled Receptors as Potential Drug Target: From Receptor Topology to Rational Drug Design, an in-silico Approach 48
Synthesis, ligand-receptor modeling studies and pharmacological evaluation of novel 4-modified-2-aryl-1,2,4-triazolo[4,3-a]quinoxalin-1-one derivatives as potent and selective human A(3) adenosine receptor antagonists 42
Human A(3) Adenosine Receptor as Versatile G Protein-Coupled Receptor Example to Validate the Receptor Homology Modeling Technology 38
New 2-arylpyrazolo[3,4-c]quinoline derivatives as potent and selective human A(3) adenosine receptor antagonists. Synthesis, pharmacological evaluation, and ligand-receptor modeling studies 37
Totale 586
Categoria #
all - tutte 2.596
article - articoli 2.292
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.888


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020139 19 1 8 9 15 14 11 18 11 15 9 9
2020/2021113 5 11 1 13 4 14 0 10 16 8 15 16
2021/2022106 0 7 12 15 4 3 2 22 6 1 13 21
2022/2023102 17 0 0 7 24 19 0 13 14 0 6 2
2023/202468 2 7 18 7 5 6 2 9 1 2 4 5
Totale 586